Cenobamate is an antiseizure medication (ASM) approved by the FDA in 2019 for focal seizures. For patients with refractory focal epilepsy, randomized control clinical trials have demonstrated that cenobamate is effective and well-tolerated.[1] However, there are currently minimal data regarding cenobamate use in pregnancy, apart from animal studies suggesting possible teratogenicity.[2]
25
MAY
MAY
0